Although the Netrin-1 level in the peripheral system is changed widely in a large number of diseases, it might bear the potential as a biomarker in diseases of the similar type (such as cancer) or sharing a similar mechanism (such as inflammation). This evidence concerns the gene NTN1 and cancer.